Skip to main navigation

Skip to Content

Overview
Stock Information
News & Events
Financials
- SEC Filings
- Analyst Coverage
Governance
- Governance Highlights
- Committee Composition
Investor Resources

News Releases

2018 Investor Presentation

Year

Jun 29, 2021

Harmony Biosciences Initiates A Phase 2 Clinical Trial In Myotonic Dystrophy

Jun 10, 2021

Harmony Biosciences Presents New Analysis Of Clinical Impact For WAKIX® (pitolisant) At The SLEEP 2021 Annual Meeting

Jun 09, 2021

Harmony Biosciences Announces Applications for 2021 Patients At The Heart Grant Program Open June 9

Jun 07, 2021

Harmony Biosciences To Present New Data Analyses For WAKIX® (pitolisant) At The SLEEP 2021 Annual Meeting

May 26, 2021

Harmony Biosciences to Participate in Three Investor Conferences in June

May 18, 2021

John C. Jacobs, President and CEO of Harmony Biosciences, Joins Life Sciences Pennsylvania Board of Directors

May 18, 2021

Harmony Biosciences to Present at the Oppenheimer Rare and Orphan Disease Summit

May 11, 2021

Harmony Biosciences Reports First Quarter 2021 Results and Business Updates

Apr 27, 2021

Harmony Biosciences Announces Date of First Quarter 2021 Financial Results

Apr 27, 2021

Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 18

Site - Shareholder Tools

Copyright © 2021 Harmony Biosciences All rights reserved.

Facebook
Twitter
LinkedIn
Google+